Cancer detection rates were 6·4 per 1,000 screened in the group that underwent mammography with AI use compared to five per 1 ...

Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.

Groundbreaking Randomized MASAI Trial Demonstrates Transpara® plays a vital role in improving early detection, leading to ...

New technology, which hundred of thousands of women will be invited to help test over the coming months, could improve ...

Nearly 700,000 women across the country will take part in a world-leading trial to test how cutting-edge AI tools can be used to catch breast cancer cases earlier, the Department of Health and Social ...

The new data will help researchers train next-generation AI models that are applicable to ethnically and demographically ...

In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative ...

Panjim: The Goa Health Department, alongside AstraZeneca and Qure.ai, is launching multiple initiatives to improve cancer ...

Nearly 700,000 women across the UK will take part in an NHS Artificial Intelligence (AI) trial designed to detect breast ...

In a development that could redefine the future of cancer diagnostics, two Bengaluru-based innovators—Dr. Narayana ...

A new artificial intelligence model developed by Stanford Medicine combines clinical notes and pathology images to predict ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...